New DBS device for Parkinson’s approved for US patients

News

Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story

Comments


Related articles


kinetics-lead

Europe

An inspiring play about Parkinson’s and Parkour is coming to a theatre near you

What can a teenage boy and woman with Parkinson’s have in common?

READ MORE
Bas Bloem-US-tour

PD in Practice

The ‘Starbucks formula’: a new approach to Parkinson’s treatment that’s going global

Parkinson’s healthcare scheme where the patient is a partner

READ MORE
Emotions of PD

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Unmasking the emotions of Parkinson’s

READ MORE